ADSC-conditioned media elicit an ex vivo anti-inflammatory macrophage response

  • Maria Jacoba Kruger
    Division of Endocrinology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
  • Maria Martha Conradie
    Division of Endocrinology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
  • Magda Conradie
    Division of Endocrinology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
  • Mari van de Vyver
    Division of Endocrinology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

Bibliographic Information

Published
2018-11
DOI
  • 10.1530/jme-18-0078
Publisher
Bioscientifica

Search this article

Description

<jats:p>Obesity-associated inflammatory mechanisms play a key role in the pathogenesis of metabolic-related diseases. Failure of anti-inflammatory control mechanisms within adipose tissue and peripheral blood mononuclear cells (PBMCs) have been implicated in disease progression. This study investigated the efficacy of allogeneic adipose tissue-derived mesenchymal stem cells conditioned media (ADSC-CM) to counteract persistent inflammation by inducing an anti-inflammatory phenotype and cytokine response within PBMCs derived from patients with and without metabolic syndrome. Forty-six (<jats:italic>n</jats:italic> = 46) mixed ancestry females (18–45 years) were subdivided into (a) healthy lean (HL) (<jats:italic>n</jats:italic> = 10) (BMI <25 kg/m<jats:sup>2</jats:sup>), (b) overweight/obese (OW/OB) (BMI ≥25 kg/m<jats:sup>2</jats:sup>, <3 metabolic risk factors) (<jats:italic>n</jats:italic> = 22) and (c) metabolic syndrome (MetS) (visceral adiposity, ≥3 metabolic risk factors) (<jats:italic>n</jats:italic> = 14) groups. Body composition (DXA scan), metabolic (cholesterol, HDL, LDL, triglycerides, blood glucose) and inflammatory profiles (38-Plex cytokine panel) were determined. PBMCs were isolated from whole blood and treated <jats:italic>ex vivo</jats:italic> with either (i) autologous participant-derived serum, (ii) ADSCs-CM or (iii) a successive treatment regime. The activation status (CD11b+) and intracellular cytokine (IL6, IL10, TNFa) expression were determined in M1 (CD68+CD206−CD163−) and M2 (CD68+CD163+ CD206+) macrophage populations using flow cytometry. ADSC-CM treatment, promoted a M2 macrophage phenotype and induced IL10 expression, this was most pronounced in the OW/OB group. This response is likely mediated by multiple complementing factors within ADSC-CM, yet to be identified. This study is the first to demonstrate the therapeutic potential of ADSC-CM to restore the inflammatory balance in immune compromised obese individuals.</jats:p>

Journal

Citations (2)*help

See more

Report a problem

Back to top